BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12482130)

  • 1. Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.
    Case CC; Wirfel K; Vassilopoulou-Sellin R
    Med Oncol; 2002; 19(3):181-7. PubMed ID: 12482130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
    Shaib W; Mitchell K; Saif MW
    Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hepatic vipoma.
    Ayub A; Zafar M; Abdulkareem A; Ali MA; Lingawi T; Harbi A
    Am J Gastroenterol; 1993 Jun; 88(6):958-61. PubMed ID: 8389095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intractable and dramatic diarrhea in liver transplantation recipient with vasoactive intestinal peptide-producing tumor after split liver transplantation: a case report.
    Haiqing W; Jiayin Y; Jian Y; Lunan Y
    Transplant Proc; 2015; 47(1):171-3. PubMed ID: 25596962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
    Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
    Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic vipoma arising from colonic primary tumour.
    Bradley C; Haddock G; Pickard RG; Rankin EM
    Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases.
    Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H
    Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIPoma syndrome: challenges in management.
    Adam N; Lim SS; Ananda V; Chan SP
    Singapore Med J; 2010 Jul; 51(7):e129-32. PubMed ID: 20730389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.
    Angelousi A; Koffas A; Grozinsky-Glasberg S; Gertner J; Kassi E; Alexandraki K; Caplin ME; Kaltsas G; Toumpanakis C
    Pancreas; 2019 Aug; 48(7):934-942. PubMed ID: 31268974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threating diarrhea and acute renal failure secondary to pancreatic VIPoma treated by surgery.
    Lapeña Rodríguez M; Cholvi Calduch R; Muñoz Forner E; Garcés Albir M; Sabater Ortí L
    Rev Esp Enferm Dig; 2019 Aug; 111(8):641-643. PubMed ID: 31232078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic VIPomas: subject review and one institutional experience.
    Ghaferi AA; Chojnacki KA; Long WD; Cameron JL; Yeo CJ
    J Gastrointest Surg; 2008 Feb; 12(2):382-93. PubMed ID: 17510774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
    Cavalli T; Giudici F; Santi R; Nesi G; Brandi ML; Tonelli F
    Fam Cancer; 2016 Oct; 15(4):645-9. PubMed ID: 27071757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute renal failure caused by VIP-secreting tumor].
    Lambertini D; Bottini E; Talassi E; Tarchini R; Gaetti L; Bellomi A
    G Ital Nefrol; 2003; 20(4):419-22. PubMed ID: 14523904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vipoma of the pancreas complicating ulcerative colitis.
    Yanagi H; Kusunoki M; Sakanoue Y; Shoji Y; Yamamura T; Murai M; Kikkawa N; Utsunomiya J
    Am J Gastroenterol; 1991 Aug; 86(8):1066-9. PubMed ID: 1650130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide secreting pancreatic tumour with hepatic metastases: long term survival after orthotopic liver transplantation.
    Johnston PC; Ardill JE; Johnston BT; Mc Cance DR
    Ir J Med Sci; 2010 Sep; 179(3):439-41. PubMed ID: 18825477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
    Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
    Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
    Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
    Song S; Shi R; Li B; Liu Y
    Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.